The influence of dose of angiotensin I-converting enzyme inhibitor on systolic blood pressure variability in heart failure: a substudy of the Assessment of Treatment with Lisinopril and Survival in heart failure (ATLAS) trial.
Saved in:
| Title: | The influence of dose of angiotensin I-converting enzyme inhibitor on systolic blood pressure variability in heart failure: a substudy of the Assessment of Treatment with Lisinopril and Survival in heart failure (ATLAS) trial. |
|---|---|
| Authors: | Giles TD; Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA. tgiles@lsuhsc.edu, Kerut EK, Roffidal LE, Jones R, Given MB, Hutchinson H, Tresznewsky O |
| Source: | Blood pressure monitoring [Blood Press Monit] 2001 Apr; Vol. 6 (2), pp. 81-4. |
| Publication Type: | Clinical Trial; Journal Article |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9606438 Publication Model: Print Cited Medium: Print ISSN: 1359-5237 (Print) Linking ISSN: 13595237 NLM ISO Abbreviation: Blood Press Monit Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
